Lihop, Mercy S.
HRN: 23-35-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2023
MUPIROCIN 2%, 15G (TUBE)
07/25/2023
07/25/2023
TOPICAL
2%
Prepare 3pcs For Bedside Use
Nasal Polyp
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes